ENOV Enovis Corporation
$19.28▲ +4.73%
Healthcare
Other
After hours
$19.10▼ -0.93%
Sep 11, 7:54 PM ET
Volume 2.59M
Avg Volume (10D) 1.99M
Key Metrics & Fundamentals
Market Cap
$1.11B
P/E Ratio
–
Div Yield
–%
52W Range
18.09 - 34.28
% vs 50 MA
-27.32%
% vs 200 MA
-25.19%
RSI-14
29.7
MACD Histogram
-0.6300
Beta (1Y vs SPY)
1.48
Free Cash Flow
$31.14M
Gross Rev
$582.78M
Gross Profit
$359.25M
EBITDA
$91.39M
COGS
$223.53M
Operating Exp
$336.98M
Operating Income
$22.27M
EBIT
$22.27M
Pretax Income
$7.47M
Net Income
-$1.19M
EPS (Diluted)
-0.02
Price & Volume History
Loading chart…
Recent News

Q2 Earnings Highlights: Enovis (NYSE:ENOV) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
StockStory · Sep 4, 2026 4:46 PM

Enovis (ENOV) Stock Fair Value Falls As Analysts Weigh Robotics And Margin Pressure
Simply Wall St. · Sep 4, 2026 7:06 AM

What Makes Enovis (ENOV) a New Buy Stock
Zacks · Sep 3, 2026 4:00 PM

Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks · Sep 3, 2026 1:35 PM

Avenzo Therapeutics Announces Appointment of Barbara Bodem and Elizabeth Mily to Board of Directors as Independent Directors
Business Wire · Sep 3, 2026 1:00 PM

Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition
Zacks · Sep 2, 2026 5:33 PM
Enovis inks eCential takeover to develop surgical ortho robots
MedTech Dive · Sep 2, 2026 10:00 AM
Top Midday Decliners
MT Newswires · Sep 1, 2026 6:21 PM
BMO Capital Adjusts Enovis Price Target to $27 From $30, Maintains Outperform Rating
MT Newswires · Sep 1, 2026 4:56 PM

Enovis Targets Robotic Surgery Expansion With €155M eCential Robotics Deal
MarketBeat · Sep 1, 2026 2:03 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ENOV's money flow as a full page
Social Sentiment
No Reddit posts found for ENOV.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.